Send to:

Choose Destination
See comment in PubMed Commons below
Menopause Int. 2012 Jun;18(2):68-72. doi: 10.1258/mi.2012.012008.

Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.

Author information

  • 1Department of Obstetrics and Gynaecology, Guy’s and St Thomas’ Hospital, London, UK.


Gonadotrophin receptor hormone analogues (GnRHa) have been used in a range of sex hormone-dependent disorders. In the management of premenstrual syndrome, they can completely abolish symptoms. The success of GnRHa in the treatment of endometriosis and adjuvant therapy in the management of fibroids is proven. This efficacy does not come without a cost and the side-effects of the hypo-estrogenic state have limited their application. The use of add-back therapy to counter these effects has enabled wider application, longer durations of treatment and an increase in compliance. This review article is an update on the evidence supporting gonadotrophin receptor hormone analogues in combination with add-back therapy.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk